CV Sciences, Inc. engages in the development, manufacture, and sale of herbal supplements, CBD products and plant-based food products. The company is headquartered in San Diego, California and currently employs 42 full-time employees. The company went IPO on 2018-10-04. The firm develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Mr. Joseph Dowling est le Chief Executive Officer de CV Sciences Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action CVSI ?
Le prix actuel de CVSI est de $0.03, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de CV Sciences Inc ?
CV Sciences Inc appartient à l'industrie Consumer products et le secteur est Consumer Staples
Quel est la capitalisation boursière de CV Sciences Inc ?
La capitalisation boursière actuelle de CV Sciences Inc est de $5.8M
Est-ce que CV Sciences Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour CV Sciences Inc, y compris 0 achat fort, 0 achat, 3 maintien, 1 vente et 0 vente forte